positionForPages[83]={page:83,positions:[{w:"75",p:[0.890196,0.957873,0.907378,0.957873,0.907378,0.938882,0.890196,0.938882,0.008591,0.008591]},{w:"3",p:[0.941813,0.310836,0.963291,0.310836,0.963291,0.263358,0.941813,0.263358,0.021478]},{w:"PATIENT-DERIVED OVARIAN CANCER ORGANOIDS MIMIC CLINICAL RESPONSE AND",p:[0.411230,0.057372,0.882353,0.057372,0.882353,0.040253,0.411230,0.040253,0.007583,0.007097,0.006387,0.003511,0.006985,0.008759,0.005640,0.005155,0.008423,0.006985,0.008423,0.003511,0.007620,0.006985,0.008423,0.002988,0.008328,0.006966,0.007919,0.008423,0.003511,0.007919,0.008759,0.002988,0.008178,0.007919,0.008759,0.008255,0.006985,0.008423,0.002988,0.008442,0.008311,0.008292,0.007919,0.008759,0.008442,0.003511,0.008423,0.007807,0.002988,0.011112,0.003511,0.011112,0.003511,0.008255,0.002988,0.008255,0.006481,0.003511,0.008759,0.003511,0.008177,0.007919,0.006294,0.002988,0.008423,0.006871,0.007807,0.008050,0.008442,0.008759,0.007807,0.006985,0.002801,0.007919,0.008759,0.008423]},{w:"EXHIBIT HETEROGENEOUS INTER- AND INTRAPATIENT DRUG RESPONSES",p:[0.468171,0.073247,0.882352,0.073247,0.882352,0.056128,0.468171,0.056128,0.006985,0.007527,0.008685,0.003511,0.008236,0.003511,0.006201,0.002988,0.008685,0.006985,0.006387,0.006985,0.008309,0.008442,0.008404,0.006985,0.008759,0.006985,0.008442,0.008367,0.007807,0.002988,0.003511,0.008759,0.006387,0.006985,0.008423,0.005155,0.002800,0.007919,0.008759,0.008423,0.002988,0.003511,0.008759,0.006387,0.008423,0.007919,0.007581,0.007097,0.006387,0.003511,0.006985,0.008759,0.006201,0.002988,0.008423,0.008367,0.008367,0.008404,0.002988,0.008423,0.006873,0.007807,0.008050,0.008442,0.008759,0.007807,0.006871,0.007807]},{w:"point, stresses the need for functional testing in addition to genetic testing to improve ",p:[0.147059,0.121273,0.886462,0.121273,0.886462,0.100900,0.147059,0.100900,0.011505,0.010843,0.005615,0.011391,0.006437,0.004497,0.005739,0.007510,0.006437,0.007442,0.009039,0.007533,0.007875,0.009039,0.007670,0.005741,0.006620,0.011299,0.009039,0.005739,0.011598,0.009106,0.009108,0.011391,0.005741,0.006026,0.010843,0.007807,0.005739,0.006369,0.011413,0.011596,0.009108,0.006437,0.005547,0.010843,0.011687,0.009405,0.005250,0.005739,0.006209,0.009039,0.007510,0.006437,0.005615,0.011459,0.009861,0.005741,0.005615,0.011756,0.005739,0.009291,0.011322,0.011391,0.005273,0.006437,0.005547,0.010843,0.011756,0.005741,0.006209,0.011048,0.005739,0.009656,0.009039,0.011598,0.009128,0.006437,0.005547,0.008994,0.005741,0.006209,0.009039,0.007510,0.006437,0.005615,0.011459,0.009861,0.005739,0.006211,0.011048,0.005741,0.005615,0.017280,0.011071,0.007442,0.010866,0.009633,0.009039,0.004109]},{w:"clinical decision making.",p:[0.147059,0.141852,0.355693,0.141852,0.355693,0.121479,0.147059,0.121479,0.008765,0.005250,0.005615,0.011756,0.005547,0.009108,0.009405,0.005250,0.004109,0.011322,0.009106,0.008994,0.005615,0.007601,0.005547,0.010843,0.011756,0.004109,0.017577,0.009405,0.010706,0.005615,0.011459,0.009679,0.004497]},{w:"The establishment of a larger collection of OC PDOs will provide the opportunity to ",p:[0.147059,0.183009,0.886498,0.183009,0.886498,0.162636,0.147059,0.162636,0.011470,0.011311,0.009039,0.006449,0.009039,0.007510,0.006551,0.009108,0.010911,0.005250,0.005615,0.007556,0.011459,0.017485,0.009039,0.011391,0.006437,0.006460,0.010843,0.006209,0.006449,0.009291,0.006460,0.005433,0.009085,0.007624,0.009656,0.009039,0.007807,0.006449,0.008994,0.010934,0.005387,0.005182,0.009108,0.009108,0.006437,0.005547,0.010843,0.011756,0.006449,0.010843,0.006209,0.006460,0.016778,0.014678,0.006449,0.011664,0.016504,0.016253,0.007670,0.006449,0.014723,0.005752,0.005387,0.005250,0.006449,0.011071,0.007442,0.010866,0.009838,0.005547,0.011322,0.009039,0.006460,0.006620,0.011299,0.009039,0.006449,0.010820,0.011048,0.011505,0.010843,0.007967,0.006163,0.011413,0.011756,0.005273,0.006437,0.009724,0.006449,0.006209,0.011048,0.004109]},{w:"determine comprehensive, clinically useful genotype-phenotype correlations. When a ",p:[0.147059,0.203588,0.886512,0.203588,0.886512,0.183215,0.147059,0.183215,0.011322,0.009131,0.006209,0.009039,0.007807,0.017645,0.005615,0.011596,0.009039,0.006460,0.008994,0.010843,0.017280,0.011071,0.007442,0.008948,0.011299,0.009039,0.011619,0.007601,0.005547,0.009633,0.008743,0.004497,0.006460,0.008765,0.005250,0.005615,0.011756,0.005547,0.009106,0.009405,0.005387,0.005182,0.009724,0.006460,0.011413,0.007875,0.009039,0.006366,0.011553,0.005250,0.006449,0.009656,0.009039,0.011596,0.010820,0.006437,0.009724,0.011505,0.009039,0.007533,0.011162,0.011299,0.009039,0.011596,0.010820,0.006437,0.009724,0.011505,0.009039,0.006449,0.008994,0.010845,0.007807,0.007444,0.008948,0.005430,0.008813,0.006437,0.005545,0.010845,0.011619,0.007670,0.004497,0.006460,0.020704,0.011299,0.009039,0.011756,0.006460,0.009291,0.004109]},{w:"large collection including drug response data is available, treatment stratification can ",p:[0.147059,0.224167,0.886510,0.224167,0.886510,0.203794,0.147059,0.203794,0.005433,0.009085,0.007624,0.009656,0.009039,0.006894,0.008994,0.010934,0.005387,0.005182,0.009108,0.009108,0.006437,0.005547,0.010843,0.011756,0.006894,0.005615,0.011596,0.008765,0.004908,0.011345,0.011391,0.005615,0.011459,0.009861,0.006894,0.011391,0.007967,0.011413,0.009861,0.006894,0.007442,0.009039,0.007510,0.011505,0.010843,0.011619,0.007875,0.009039,0.006894,0.011573,0.008811,0.006551,0.009291,0.006894,0.005615,0.007670,0.006894,0.008928,0.009838,0.009085,0.005750,0.005435,0.009106,0.010911,0.005182,0.008745,0.004497,0.006894,0.006437,0.007442,0.009291,0.008811,0.006437,0.017485,0.009039,0.011391,0.006437,0.006894,0.007510,0.006437,0.007898,0.008811,0.006437,0.005615,0.005684,0.005615,0.009106,0.008811,0.006437,0.005547,0.010843,0.011756,0.006894,0.009108,0.009085,0.011756,0.004109]},{w:"potentially be performed based on genomic or transcriptomic characteristics of specific ",p:[0.147059,0.244745,0.886482,0.244745,0.886482,0.224373,0.147059,0.224373,0.011505,0.010820,0.006209,0.009039,0.011391,0.006437,0.005798,0.009405,0.005385,0.005184,0.009724,0.004406,0.011251,0.009039,0.004406,0.011502,0.009039,0.007807,0.006026,0.010843,0.007807,0.017485,0.009108,0.011391,0.004406,0.011117,0.009291,0.007875,0.009108,0.011391,0.004406,0.010843,0.011756,0.004406,0.009656,0.009039,0.011596,0.010843,0.017645,0.005547,0.008994,0.004406,0.010843,0.007807,0.004406,0.006437,0.007898,0.009087,0.011617,0.007875,0.008994,0.007807,0.005273,0.011048,0.006209,0.010843,0.017645,0.005547,0.008994,0.004406,0.008765,0.011391,0.009085,0.007898,0.009291,0.009108,0.006209,0.009039,0.007807,0.005615,0.007510,0.006437,0.005547,0.008994,0.007670,0.004406,0.010843,0.006209,0.004406,0.007510,0.011505,0.009108,0.008994,0.005615,0.005684,0.005615,0.008994,0.004109]},{w:"PDO subtypes, which could make organoid derivation dispensable in the future . This ",p:[0.147059,0.265324,0.886454,0.265324,0.886454,0.244951,0.147059,0.244951,0.011664,0.016504,0.016412,0.004406,0.007510,0.011345,0.010797,0.006437,0.009724,0.011505,0.009039,0.007670,0.004497,0.004406,0.014792,0.011459,0.005547,0.008765,0.011459,0.004406,0.008994,0.010818,0.011553,0.005182,0.011391,0.004406,0.017577,0.009405,0.010272,0.009039,0.004406,0.010843,0.007624,0.009861,0.009085,0.011598,0.010843,0.005547,0.011391,0.004406,0.011322,0.009039,0.007807,0.005547,0.009838,0.008811,0.006437,0.005547,0.010843,0.011756,0.004406,0.011391,0.005615,0.007510,0.011505,0.009039,0.011619,0.007944,0.009108,0.010911,0.005182,0.009039,0.004406,0.005615,0.011756,0.004406,0.006620,0.011299,0.009039,0.004406,0.006369,0.011071,0.006163,0.011413,0.007442,0.009039,0.018318,0.004497,0.004406,0.011470,0.011470,0.005615,0.007670,0.004109]},{w:"312",p:[0.818972,0.257708,0.837217,0.257708,0.837217,0.245831,0.818972,0.245831,0.006082,0.006082,0.006082]},{w:"transition requires an accurate classification of drug-sensitive and -resistant PDOs. Sim-",p:[0.147059,0.285903,0.882353,0.285903,0.882353,0.265530,0.147059,0.265530,0.006437,0.007898,0.009085,0.011619,0.007601,0.005273,0.006437,0.005547,0.010843,0.011756,0.003972,0.007442,0.009108,0.010706,0.011413,0.005615,0.007442,0.009039,0.007670,0.003972,0.009085,0.011756,0.003972,0.009291,0.008994,0.009108,0.011413,0.007898,0.008811,0.006209,0.009039,0.003972,0.008765,0.005433,0.009291,0.007533,0.007601,0.005615,0.005684,0.005615,0.009108,0.008809,0.006437,0.005547,0.010843,0.011756,0.003972,0.010840,0.006209,0.003972,0.011391,0.007964,0.011413,0.009861,0.007533,0.007875,0.009039,0.011619,0.007601,0.005273,0.006437,0.005547,0.009633,0.009039,0.003972,0.009085,0.011596,0.011391,0.003972,0.007533,0.007442,0.009039,0.007601,0.005615,0.007510,0.006551,0.009085,0.011391,0.006437,0.003972,0.011664,0.016504,0.016253,0.007670,0.004497,0.003972,0.010112,0.005615,0.017604,0.007533]},{w:"ilar to previous studies",p:[0.147059,0.306482,0.343027,0.306482,0.343027,0.286109,0.147059,0.286109,0.005752,0.005433,0.009085,0.007807,0.006277,0.006209,0.011048,0.006277,0.011071,0.007442,0.009336,0.009838,0.005547,0.010820,0.011413,0.007670,0.006277,0.007510,0.006166,0.011345,0.011391,0.005545,0.009039,0.007670]},{w:"288,289",p:[0.343041,0.298866,0.382154,0.298866,0.382154,0.286988,0.343041,0.286988,0.006082,0.006082,0.006082,0.002622,0.006082,0.006082,0.006082]},{w:", OC PDOs were considered highly responsive if the drug ",p:[0.382152,0.306482,0.886419,0.306482,0.886419,0.286109,0.382152,0.286109,0.004497,0.006277,0.016778,0.014678,0.006277,0.011664,0.016504,0.016253,0.007670,0.006277,0.014518,0.009039,0.007442,0.009039,0.006277,0.008994,0.010840,0.011619,0.007604,0.005547,0.011322,0.009039,0.007442,0.009106,0.011391,0.006277,0.011459,0.005615,0.009930,0.011573,0.005182,0.009724,0.006277,0.007442,0.009039,0.007510,0.011505,0.010843,0.011619,0.007601,0.005547,0.009635,0.009039,0.006277,0.005615,0.006209,0.006277,0.006620,0.011299,0.009039,0.006277,0.011391,0.007967,0.011413,0.009861,0.004109]},{w:"concentration that reduced viability of >50% of cells was lower than the concentration ",p:[0.147059,0.327060,0.886484,0.327060,0.886484,0.306687,0.147059,0.306687,0.008994,0.010843,0.011596,0.008994,0.009039,0.011391,0.006437,0.007898,0.008811,0.006437,0.005547,0.010843,0.011756,0.005478,0.006620,0.011391,0.008811,0.006437,0.005478,0.007439,0.009108,0.011048,0.011345,0.008994,0.009108,0.011391,0.005478,0.009838,0.005796,0.009108,0.010820,0.005752,0.005250,0.005273,0.006437,0.009724,0.005478,0.010843,0.006209,0.005478,0.011550,0.010432,0.010432,0.015043,0.005478,0.010843,0.006209,0.005478,0.008994,0.008948,0.005387,0.005250,0.007670,0.005478,0.014723,0.009291,0.007670,0.005478,0.005182,0.010866,0.014518,0.009039,0.007807,0.005478,0.006620,0.011393,0.009085,0.011756,0.005478,0.006620,0.011299,0.009039,0.005478,0.008994,0.010843,0.011596,0.008994,0.009039,0.011391,0.006437,0.007898,0.008811,0.006437,0.005547,0.010843,0.011756,0.004109]},{w:"achievable in patient plasma (C /C",p:[0.147059,0.347639,0.455887,0.347639,0.455887,0.327266,0.147059,0.327266,0.009291,0.008765,0.011459,0.005547,0.009336,0.009838,0.009108,0.010911,0.005182,0.009039,0.006255,0.005615,0.011756,0.006255,0.011368,0.008811,0.006437,0.005547,0.009039,0.011391,0.006437,0.006255,0.011162,0.005433,0.009291,0.007601,0.017577,0.009291,0.006255,0.006939,0.014678,0.015184,0.007099,0.014678]},{w:"ss max",p:[0.418953,0.348108,0.495673,0.348108,0.495673,0.326086,0.418953,0.326086,0.007464,0.007693,0.021776,0.017805,0.011185,0.010797]},{w:"). However, the ",p:[0.495673,0.347639,0.631036,0.347639,0.631036,0.327266,0.495673,0.327266,0.006939,0.004497,0.006255,0.016207,0.010866,0.014518,0.009336,0.009633,0.009039,0.006255,0.004497,0.006255,0.006620,0.011299,0.009039,0.004109]},{w:"Css/Cmax",p:[0.633202,0.348108,0.724167,0.348108,0.724167,0.326086,0.633202,0.326086,0.014495,0.007464,0.007693,0.007350,0.014175,0.017805,0.011185,0.010797]},{w:" will vary between ",p:[0.724166,0.347639,0.886442,0.347639,0.886442,0.327266,0.724166,0.327266,0.006255,0.014723,0.005752,0.005387,0.005250,0.006255,0.009838,0.009085,0.008400,0.009724,0.006255,0.011254,0.009131,0.006437,0.014518,0.009108,0.009039,0.011756,0.004109]},{w:"patients and is not necessarily the concentration that is achieved in the tumor",p:[0.147059,0.368218,0.814240,0.368218,0.814240,0.347845,0.147059,0.347845,0.011368,0.008811,0.006437,0.005547,0.009039,0.011391,0.006437,0.007670,0.005821,0.009085,0.011596,0.011391,0.005821,0.005615,0.007670,0.005821,0.011596,0.010820,0.006437,0.005821,0.011596,0.009108,0.008994,0.009039,0.007533,0.007944,0.009085,0.007807,0.005752,0.005182,0.009724,0.005821,0.006620,0.011299,0.009039,0.005821,0.008994,0.010843,0.011596,0.008994,0.009039,0.011391,0.006437,0.007898,0.008811,0.006437,0.005547,0.010843,0.011756,0.005821,0.006617,0.011393,0.008811,0.006437,0.005821,0.005615,0.007670,0.005821,0.009291,0.008765,0.011459,0.005547,0.009336,0.009633,0.009108,0.011391,0.005821,0.005615,0.011756,0.005821,0.006620,0.011299,0.009039,0.005821,0.006163,0.011413,0.017485,0.010843,0.007807]},{w:"313,314",p:[0.814272,0.360602,0.853384,0.360602,0.853384,0.348724,0.814272,0.348724,0.006082,0.006082,0.006082,0.002622,0.006082,0.006082,0.006082]},{w:". In ",p:[0.853383,0.368218,0.886459,0.368218,0.886459,0.347845,0.853383,0.347845,0.004497,0.005821,0.006894,0.011756,0.004109]},{w:"addition, sometimes patients require dose adjustments due to adverse events which also ",p:[0.147059,0.388796,0.886507,0.388796,0.886507,0.368423,0.147059,0.368423,0.009291,0.011322,0.011391,0.005273,0.006437,0.005547,0.010843,0.011756,0.004497,0.004223,0.007875,0.010843,0.017485,0.009131,0.006437,0.005615,0.017485,0.009039,0.007670,0.004223,0.011368,0.008811,0.006437,0.005547,0.009039,0.011391,0.006437,0.007670,0.004223,0.007442,0.009108,0.010706,0.011413,0.005615,0.007442,0.009039,0.004223,0.011322,0.010957,0.007875,0.009039,0.004223,0.009291,0.011048,0.004953,0.011413,0.007510,0.006437,0.017485,0.009039,0.011391,0.006437,0.007670,0.004223,0.011048,0.011345,0.009039,0.004223,0.006209,0.011048,0.004223,0.009291,0.011322,0.009635,0.009039,0.007622,0.007875,0.009039,0.004223,0.009334,0.009635,0.009039,0.011391,0.006437,0.007670,0.004223,0.014792,0.011459,0.005549,0.008763,0.011459,0.004223,0.009405,0.005250,0.007873,0.011048,0.004109]},{w:"affect the drug concentration achievable in both plasma and tumor. Therefore, it should ",p:[0.147059,0.409375,0.886418,0.409375,0.886418,0.389002,0.147059,0.389002,0.009085,0.005969,0.005787,0.009108,0.009108,0.006437,0.004428,0.006620,0.011299,0.009039,0.004428,0.011391,0.007967,0.011413,0.009861,0.004428,0.008994,0.010843,0.011596,0.008994,0.009039,0.011391,0.006437,0.007898,0.008811,0.006437,0.005547,0.010843,0.011756,0.004428,0.009291,0.008765,0.011459,0.005547,0.009336,0.009838,0.009108,0.010911,0.005182,0.009039,0.004428,0.005615,0.011756,0.004428,0.011251,0.010820,0.006620,0.011459,0.004428,0.011162,0.005433,0.009291,0.007601,0.017577,0.009291,0.004428,0.009087,0.011596,0.011391,0.004428,0.006163,0.011413,0.017485,0.010843,0.006255,0.004497,0.004428,0.011470,0.011311,0.009039,0.007442,0.009039,0.006026,0.010843,0.007442,0.008743,0.004497,0.004428,0.005273,0.006437,0.004428,0.007556,0.011299,0.010820,0.011550,0.005182,0.011391,0.004109]},{w:"be taken into account that tumors predicted to be highly responsive based on the PDO ",p:[0.147059,0.429954,0.886398,0.429954,0.886398,0.409581,0.147059,0.409581,0.011254,0.009039,0.004839,0.006551,0.009405,0.010272,0.009039,0.011756,0.004839,0.005615,0.011391,0.006209,0.011048,0.004839,0.009291,0.008994,0.008994,0.010820,0.011413,0.011391,0.006437,0.004839,0.006620,0.011391,0.008813,0.006437,0.004839,0.006163,0.011413,0.017485,0.010843,0.007624,0.007670,0.004839,0.011071,0.007442,0.009108,0.011391,0.005547,0.009108,0.006209,0.009108,0.011391,0.004839,0.006209,0.011048,0.004839,0.011254,0.009039,0.004839,0.011459,0.005615,0.009930,0.011573,0.005182,0.009724,0.004839,0.007442,0.009039,0.007510,0.011505,0.010843,0.011619,0.007601,0.005547,0.009633,0.009039,0.004839,0.011117,0.009291,0.007875,0.009108,0.011391,0.004839,0.010843,0.011756,0.004839,0.006620,0.011299,0.009039,0.004839,0.011664,0.016504,0.016412,0.004109]},{w:"drug response may clinically not respond. Prospective clinical trials comparing clinical ",p:[0.147059,0.450532,0.886434,0.450532,0.886434,0.430160,0.147059,0.430160,0.011391,0.007967,0.011413,0.009861,0.005113,0.007442,0.009039,0.007510,0.011505,0.010843,0.011619,0.007875,0.009039,0.005113,0.017577,0.008925,0.009724,0.005113,0.008765,0.005250,0.005615,0.011756,0.005547,0.009108,0.009402,0.005387,0.005182,0.009724,0.005113,0.011598,0.010818,0.006437,0.005113,0.007442,0.009039,0.007510,0.011502,0.010845,0.011596,0.011117,0.004497,0.005113,0.011916,0.007442,0.010957,0.007510,0.011505,0.009106,0.009108,0.006437,0.005547,0.009633,0.009039,0.005113,0.008765,0.005250,0.005615,0.011756,0.005545,0.009108,0.009405,0.005250,0.005113,0.006437,0.007807,0.005798,0.009405,0.005250,0.007670,0.005113,0.008994,0.010843,0.017280,0.011368,0.009085,0.007807,0.005615,0.011461,0.009861,0.005113,0.008765,0.005250,0.005615,0.011756,0.005545,0.009108,0.009405,0.005250,0.004109]},{w:"to PDO drug response, should be complemented with plasma drug level measurements ",p:[0.147059,0.471111,0.886528,0.471111,0.886528,0.450738,0.147059,0.450738,0.006209,0.011048,0.004337,0.011664,0.016504,0.016412,0.004337,0.011391,0.007967,0.011413,0.009861,0.004337,0.007442,0.009039,0.007510,0.011502,0.010843,0.011619,0.007875,0.008743,0.004497,0.004337,0.007556,0.011299,0.010820,0.011550,0.005182,0.011391,0.004337,0.011254,0.009039,0.004337,0.008994,0.010843,0.017280,0.011162,0.005182,0.009039,0.017485,0.009039,0.011391,0.006211,0.009106,0.011391,0.004337,0.014723,0.005273,0.006617,0.011459,0.004337,0.011162,0.005433,0.009291,0.007601,0.017577,0.009291,0.004337,0.011391,0.007967,0.011413,0.009861,0.004337,0.005182,0.009336,0.009633,0.008948,0.005250,0.004337,0.017488,0.009288,0.009291,0.007510,0.011413,0.007442,0.009039,0.017485,0.009039,0.011391,0.006437,0.007670,0.004109]},{w:"to further elucidate the relation between ",p:[0.147059,0.491690,0.488271,0.491690,0.488271,0.471317,0.147059,0.471317,0.006209,0.011048,0.004109,0.006369,0.011413,0.007967,0.006617,0.011299,0.009039,0.007807,0.004109,0.008948,0.004908,0.011345,0.008994,0.005547,0.011573,0.008811,0.006209,0.009039,0.004109,0.006620,0.011299,0.009039,0.004109,0.007442,0.008948,0.005433,0.008811,0.006437,0.005547,0.010843,0.011756,0.004109,0.011254,0.009131,0.006437,0.014518,0.009108,0.009039,0.011756,0.004109]},{w:"in vitro",p:[0.488270,0.492159,0.553440,0.492159,0.553440,0.470137,0.488270,0.470137,0.005935,0.012144,0.005227,0.010500,0.005912,0.006802,0.007921,0.010729]},{w:" and clinical responsiveness.",p:[0.553440,0.491690,0.788647,0.491690,0.788647,0.471317,0.553440,0.471317,0.004109,0.009085,0.011596,0.011391,0.004109,0.008765,0.005250,0.005615,0.011756,0.005547,0.009108,0.009405,0.005250,0.004109,0.007442,0.009039,0.007510,0.011502,0.010843,0.011619,0.007601,0.005547,0.009635,0.009039,0.011596,0.009039,0.007533,0.007670,0.004497]},{w:"To conclude, OC PDOs provide a valuable preclinical model system to guide treatment ",p:[0.147059,0.512269,0.886441,0.512269,0.886441,0.491896,0.147059,0.491896,0.010866,0.011048,0.004725,0.008994,0.010843,0.011596,0.008765,0.004908,0.011345,0.011322,0.008743,0.004497,0.004725,0.016778,0.014678,0.004725,0.011664,0.016504,0.016253,0.007670,0.004725,0.011071,0.007442,0.010866,0.009838,0.005547,0.011322,0.009039,0.004725,0.009291,0.004725,0.009838,0.009405,0.004908,0.011596,0.009108,0.010911,0.005182,0.009039,0.004725,0.011071,0.007442,0.009108,0.008765,0.005250,0.005615,0.011756,0.005547,0.009108,0.009405,0.005250,0.004725,0.017488,0.011274,0.011322,0.008948,0.005250,0.004725,0.007761,0.009724,0.007510,0.006209,0.009039,0.017645,0.004725,0.006209,0.011048,0.004725,0.009861,0.011413,0.005547,0.011322,0.009039,0.004725,0.006437,0.007442,0.009291,0.008811,0.006437,0.017485,0.009039,0.011391,0.006437,0.004109]},{w:"choice in the clinic as it satisfies the following criteria; 1) PDOs genetically resemble the ",p:[0.147059,0.532847,0.886555,0.532847,0.886555,0.512474,0.147059,0.512474,0.008765,0.011299,0.010843,0.005547,0.008994,0.009039,0.004520,0.005615,0.011756,0.004520,0.006620,0.011299,0.009039,0.004520,0.008768,0.005250,0.005615,0.011756,0.005547,0.008994,0.004520,0.009291,0.007670,0.004520,0.005271,0.006437,0.004520,0.007944,0.008811,0.006437,0.005615,0.007601,0.005684,0.005615,0.009039,0.007670,0.004520,0.006622,0.011299,0.009039,0.004520,0.006026,0.010934,0.005387,0.005182,0.010866,0.014723,0.005615,0.011459,0.009861,0.004520,0.008994,0.007807,0.005271,0.006211,0.009039,0.007807,0.005796,0.009291,0.004497,0.004520,0.010432,0.006939,0.004520,0.011664,0.016504,0.016253,0.007670,0.004520,0.009656,0.009039,0.011596,0.009131,0.006437,0.005547,0.009108,0.009405,0.005387,0.005182,0.009724,0.004520,0.007442,0.009039,0.007875,0.009039,0.017394,0.010911,0.005182,0.009039,0.004520,0.006620,0.011299,0.009039,0.004109]},{w:"original tumor from which they are derived, 2) PDO drug response often reflects pa-",p:[0.147059,0.553426,0.882353,0.553426,0.882353,0.533053,0.147059,0.533053,0.010843,0.007807,0.005615,0.009861,0.005615,0.011687,0.009405,0.005250,0.006232,0.006163,0.011413,0.017485,0.010843,0.007807,0.006232,0.006414,0.007442,0.010843,0.017645,0.006232,0.014792,0.011459,0.005547,0.008765,0.011459,0.006232,0.006620,0.011299,0.009336,0.009724,0.006232,0.009085,0.007442,0.009039,0.006232,0.011322,0.009039,0.007807,0.005547,0.009633,0.009108,0.011117,0.004497,0.006232,0.010432,0.006939,0.006232,0.011664,0.016504,0.016412,0.006232,0.011391,0.007967,0.011413,0.009861,0.006232,0.007442,0.009039,0.007512,0.011502,0.010843,0.011619,0.007875,0.009039,0.006232,0.010843,0.006197,0.005969,0.009039,0.011756,0.006232,0.007442,0.009039,0.005638,0.005567,0.009108,0.009108,0.006437,0.007670,0.006232,0.011368,0.009336,0.007533]},{w:"tients’ clinical response, and 3) PDO establishment and drug screening can be performed ",p:[0.147059,0.574005,0.886555,0.574005,0.886555,0.553632,0.147059,0.553632,0.006437,0.005547,0.009039,0.011391,0.006437,0.006277,0.004291,0.003310,0.008765,0.005250,0.005615,0.011756,0.005547,0.009106,0.009405,0.005250,0.003310,0.007442,0.009039,0.007510,0.011505,0.010843,0.011619,0.007875,0.008743,0.004497,0.003310,0.009085,0.011596,0.011391,0.003310,0.010432,0.006939,0.003310,0.011664,0.016504,0.016412,0.003310,0.009039,0.007510,0.006551,0.009108,0.010911,0.005250,0.005615,0.007556,0.011459,0.017485,0.009039,0.011391,0.006437,0.003310,0.009087,0.011596,0.011391,0.003310,0.011391,0.007967,0.011413,0.009861,0.003310,0.007875,0.008994,0.007442,0.009108,0.009039,0.011756,0.005615,0.011461,0.009861,0.003310,0.009108,0.009085,0.011756,0.003310,0.011254,0.009039,0.003310,0.011502,0.009039,0.007807,0.006026,0.010843,0.007807,0.017485,0.009108,0.011391,0.004109]},{w:"within a short timeframe. Generating and testing PDOs of multiple tumor locations will ",p:[0.147059,0.594583,0.886535,0.594583,0.886535,0.574210,0.147059,0.574210,0.014723,0.005273,0.006620,0.011459,0.005615,0.011756,0.004063,0.009291,0.004063,0.007556,0.011299,0.010843,0.007967,0.006437,0.004063,0.006437,0.005615,0.017485,0.009039,0.006414,0.007898,0.009085,0.017485,0.008743,0.004497,0.004063,0.015819,0.009039,0.011598,0.009039,0.007896,0.008811,0.006437,0.005615,0.011459,0.009861,0.004063,0.009085,0.011596,0.011391,0.004063,0.006209,0.009039,0.007512,0.006437,0.005615,0.011459,0.009861,0.004063,0.011664,0.016504,0.016253,0.007670,0.004063,0.010843,0.006209,0.004063,0.017280,0.011550,0.004908,0.006437,0.005273,0.011160,0.005184,0.009039,0.004063,0.006163,0.011413,0.017485,0.010843,0.007807,0.004063,0.005182,0.011276,0.009108,0.008811,0.006437,0.005547,0.010843,0.011619,0.007670,0.004063,0.014723,0.005752,0.005387,0.005250,0.004109]},{w:"provide insights in differential drug response as a result of tumor heterogeneity. This in-",p:[0.147059,0.615162,0.882353,0.615162,0.882353,0.594789,0.147059,0.594789,0.011071,0.007442,0.010866,0.009838,0.005547,0.011322,0.009039,0.004337,0.005615,0.011619,0.007601,0.005615,0.009927,0.011094,0.006437,0.007670,0.004337,0.005615,0.011756,0.004337,0.011391,0.005615,0.005969,0.005784,0.009039,0.007442,0.009039,0.011391,0.006437,0.005798,0.009405,0.005250,0.004337,0.011391,0.007964,0.011413,0.009861,0.004337,0.007442,0.009039,0.007510,0.011505,0.010843,0.011619,0.007875,0.009039,0.004337,0.009291,0.007670,0.004337,0.009291,0.004337,0.007442,0.009039,0.007510,0.011550,0.004908,0.006437,0.004337,0.010845,0.006209,0.004337,0.006163,0.011413,0.017485,0.010843,0.007807,0.004337,0.011299,0.009131,0.006209,0.009039,0.007442,0.011048,0.009656,0.009039,0.011596,0.009039,0.005273,0.006437,0.007989,0.004497,0.004337,0.011470,0.011470,0.005615,0.007670,0.004337,0.005615,0.011804,0.007533]},{w:"formation could improve treatment stratification and reduce the development of drug ",p:[0.147059,0.635741,0.886398,0.635741,0.886398,0.615368,0.147059,0.615368,0.006026,0.010843,0.007807,0.017577,0.008811,0.006437,0.005547,0.010843,0.011756,0.005707,0.008994,0.010820,0.011550,0.005182,0.011391,0.005707,0.005615,0.017280,0.011071,0.007442,0.010866,0.009633,0.009039,0.005707,0.006437,0.007442,0.009288,0.008811,0.006437,0.017488,0.009039,0.011391,0.006437,0.005707,0.007512,0.006437,0.007896,0.008811,0.006437,0.005615,0.005684,0.005615,0.009108,0.008811,0.006437,0.005547,0.010843,0.011756,0.005707,0.009085,0.011596,0.011391,0.005707,0.007442,0.009108,0.011048,0.011345,0.008994,0.009039,0.005707,0.006620,0.011299,0.009039,0.005707,0.011322,0.009334,0.009635,0.008946,0.005184,0.010820,0.011071,0.017485,0.009039,0.011391,0.006437,0.005707,0.010845,0.006209,0.005707,0.011391,0.007967,0.011413,0.009861,0.004109]},{w:"resistance. Complementary PDO drug screening and genomic analysis allows the link-",p:[0.147059,0.656319,0.882353,0.656319,0.882353,0.635947,0.147059,0.635947,0.007442,0.009039,0.007601,0.005615,0.007510,0.006551,0.009085,0.011596,0.008994,0.008743,0.004497,0.004976,0.014997,0.010843,0.017280,0.011162,0.005182,0.009039,0.017485,0.009039,0.011391,0.006551,0.009085,0.008400,0.009724,0.004976,0.011664,0.016504,0.016412,0.004976,0.011391,0.007967,0.011413,0.009861,0.004976,0.007875,0.008994,0.007442,0.009106,0.009039,0.011756,0.005615,0.011459,0.009861,0.004976,0.009085,0.011598,0.011391,0.004976,0.009656,0.009039,0.011596,0.010843,0.017645,0.005547,0.008994,0.004976,0.009085,0.011687,0.009405,0.005182,0.009724,0.007601,0.005615,0.007670,0.004976,0.009405,0.005387,0.005182,0.010866,0.014723,0.007670,0.004976,0.006620,0.011299,0.009039,0.004976,0.005250,0.005615,0.011870,0.010498,0.007533]},{w:"age of genotypes with drug responsiveness patterns to identify candidate biomarkers for ",p:[0.147059,0.676898,0.886510,0.676898,0.886510,0.656525,0.147059,0.656525,0.009199,0.009656,0.009039,0.004177,0.010843,0.006209,0.004177,0.009656,0.009039,0.011596,0.010820,0.006437,0.009724,0.011505,0.009039,0.007670,0.004177,0.014723,0.005273,0.006620,0.011459,0.004177,0.011391,0.007967,0.011413,0.009861,0.004177,0.007442,0.009039,0.007510,0.011505,0.010843,0.011619,0.007601,0.005547,0.009633,0.009039,0.011596,0.009039,0.007533,0.007670,0.004177,0.011368,0.008811,0.006163,0.006209,0.009039,0.007807,0.011619,0.007670,0.004177,0.006209,0.011048,0.004177,0.005547,0.011322,0.009039,0.011391,0.006437,0.005615,0.006506,0.009724,0.004177,0.009108,0.009085,0.011596,0.011391,0.005547,0.011573,0.008811,0.006209,0.009039,0.004177,0.010820,0.005547,0.010843,0.017577,0.009085,0.007601,0.010272,0.009039,0.007624,0.007670,0.004177,0.006026,0.010843,0.007807,0.004109]},{w:"drug response.",p:[0.147059,0.697477,0.270871,0.697477,0.270871,0.677104,0.147059,0.677104,0.011391,0.007967,0.011413,0.009861,0.004109,0.007442,0.009039,0.007510,0.011502,0.010845,0.011619,0.007875,0.008743,0.004497]},{w:"STAR Methods",p:[0.147059,0.779246,0.288805,0.779246,0.288805,0.751136,0.147059,0.751136,0.012028,0.009064,0.012318,0.013103,0.004648,0.017286,0.011069,0.010343,0.013509,0.013132,0.013103,0.012144]},{w:"RESOURCE AVAILABILITY",p:[0.147059,0.829179,0.369193,0.829179,0.369193,0.802159,0.147059,0.802159,0.013103,0.010749,0.012144,0.013132,0.013015,0.012928,0.012841,0.010924,0.004358,0.011301,0.010836,0.012318,0.005665,0.010139,0.012318,0.012812,0.005665,0.010139,0.005665,0.010052,0.012028]},{w:"Lead contact",p:[0.147059,0.852227,0.262278,0.852227,0.262278,0.829067,0.147059,0.829067,0.008691,0.009363,0.010558,0.011231,0.003984,0.011007,0.011256,0.011679,0.007518,0.010409,0.010907,0.008616]},{w:"Further information and requests for resources and reagents should be directed to and ",p:[0.147059,0.877982,0.886512,0.877982,0.886512,0.857609,0.147059,0.857609,0.010729,0.011413,0.007967,0.006620,0.011299,0.009039,0.007807,0.005227,0.005615,0.011756,0.006026,0.010843,0.007807,0.017577,0.008811,0.006437,0.005547,0.010843,0.011756,0.005227,0.009085,0.011598,0.011391,0.005227,0.007442,0.009108,0.010706,0.011345,0.009039,0.007510,0.006437,0.007670,0.005227,0.006026,0.010843,0.007807,0.005227,0.007442,0.009039,0.007873,0.010820,0.011413,0.007442,0.008994,0.009039,0.007670,0.005227,0.009085,0.011596,0.011391,0.005227,0.007442,0.009291,0.009199,0.009656,0.009039,0.011391,0.006437,0.007670,0.005227,0.007558,0.011299,0.010820,0.011550,0.005182,0.011391,0.005227,0.011254,0.009039,0.005227,0.011391,0.005615,0.007442,0.009108,0.009108,0.006209,0.009108,0.011391,0.005227,0.006209,0.011048,0.005227,0.009085,0.011596,0.011391,0.004109]},{w:"will be fulfilled by the Lead Contact, Ellen Stelloo (estelloo@umcutrecht.nl).",p:[0.147059,0.898560,0.784374,0.898560,0.784374,0.878187,0.147059,0.878187,0.014723,0.005752,0.005387,0.005250,0.004109,0.011251,0.009039,0.004109,0.006369,0.011550,0.005250,0.005684,0.005821,0.005387,0.005182,0.009108,0.011391,0.004109,0.010840,0.009724,0.004109,0.006620,0.011299,0.009039,0.004109,0.011824,0.009291,0.009291,0.011391,0.004109,0.014995,0.010843,0.011393,0.006549,0.009291,0.009108,0.006437,0.004497,0.004109,0.012212,0.005387,0.005182,0.009039,0.011756,0.004109,0.009793,0.006209,0.008948,0.005387,0.005182,0.011276,0.011048,0.004109,0.006939,0.009039,0.007510,0.006209,0.008948,0.005385,0.005184,0.011274,0.011048,0.016390,0.011413,0.017485,0.009108,0.011071,0.006437,0.007442,0.009108,0.008765,0.011094,0.006437,0.004497,0.011870,0.005250,0.006939,0.004497]}]};